| Panacea Biotec Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531349 |
NSE Symbol : PANACEABIO |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE922B01023 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 46.57 |
Market Cap(₹Cr) : 2,571.92 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 111.12 | 99.31 | 90.81 | 112.25 | 67.90 | 108.43 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 111.12 | 99.31 | 90.81 | 112.25 | 67.90 | 108.43 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 5.60 | 3.84 | 3.61 | 4.95 | 6.09 | 3.32 |
| Total Income | 116.72 | 103.15 | 94.42 | 117.20 | 73.99 | 111.75 |
| Total Expenditure | 110.82 | 100.69 | 104.51 | 115.27 | 86.47 | 93.04 |
| PBIDT | 5.90 | 2.46 | -10.09 | 1.93 | -12.48 | 18.71 |
| Interest | 6.33 | 7.04 | 5.93 | 6.00 | 4.64 | 3.85 |
| PBDT | -0.43 | -4.58 | -16.02 | -4.07 | -17.12 | 14.86 |
| Depreciation | 4.18 | 4.89 | 4.91 | 4.77 | 4.91 | 5.21 |
| Tax | -1.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.84 | -2.11 | -5.29 | -2.14 | -9.64 | 0.00 |
| Reported Profit After Tax | -0.18 | -7.36 | -15.64 | -6.70 | -12.39 | 9.65 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.18 | -7.36 | -15.64 | -6.70 | -12.39 | 9.65 |
| EPS (Unit Curr.) | -0.03 | -1.20 | -2.55 | -1.09 | -2.02 | 1.58 |
| EPS (Adj) (Unit Curr.) | -0.03 | -1.20 | -2.55 | -1.09 | -2.02 | 1.58 |
| Calculated EPS (Unit Curr.) | -0.03 | -1.20 | -2.55 | -1.09 | -2.02 | 1.57 |
| Calculated EPS (Adj) (Unit Curr.) | -0.03 | -1.20 | -2.55 | -1.09 | -2.02 | 1.57 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.12 | -4.80 | -10.21 | -4.37 | -8.08 | 6.30 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.12 | -4.80 | -10.21 | -4.37 | -8.08 | 6.30 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 5.31 | 2.48 | -11.11 | 1.72 | -18.38 | 17.26 |
| PBDTM(%) | -0.39 | -4.61 | -17.64 | -3.63 | -25.21 | 13.70 |
| PATM(%) | -0.16 | -7.41 | -17.22 | -5.97 | -18.25 | 8.90 |
